Previous 10 | Next 10 |
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2023 Financial Results PR Newswire WARSAW, Ind. , April 4, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its first quarter earnings conference call will b...
2023-03-15 15:04:08 ET Shares of the MedTech company ZimVie ( NASDAQ: ZIMV ) climbed ~15% , marking the highest intraday gain since November after announcing that two healthcare payers have issued positive medical policy decisions regarding vertebral body tethering (VBT). ...
2023-03-10 08:25:42 ET Zimmer Biomet ( NYSE: ZBH ) trended higher in the pre-market trading Friday after Piper Sandler upgraded it to Overweight from Neutral, arguing that the orthopedic product manufacturer has issued conservative guidance amid an upbeat joint market. The a...
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2023 PR Newswire WARSAW, Ind. , March 8, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has app...
2023-03-08 03:09:55 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
Zimmer Biomet Unveils Latest Enhancements to ZBEdge™ Dynamic Intelligence™ at AAOS 2023 Annual Meeting PR Newswire -- New Updates to mymobility ® Digital Care Management Platform, ROSA ® Knee and Persona IQ ® The Smart Knee ® t...
The shares of the MedTech company ZimVie ( NASDAQ: ZIMV ) lost ~37% in the morning hours Thursday to reach the lowest level since its 2022 IPO after reporting lower-than-expected Q4 2022 financials and setting its guidance below the consensus. ZimVie ( ZIMV ), which IPO’...
Summary Enovis came up a little short with revenue and margins for both the fourth quarter of 2022 and guidance for 2023. The Reconstructive segment is performing well, with growth in U.S. hips, knees, and extremities that was well ahead of the group. The Prevention & Recovery b...
Summary Smith & Nephew plc's fourth quarter results were mixed; Ortho is still lagging its rivals, but Sports Medicine & ENT and Advanced Wound Care outperformed. The company has the technology to be more competitive in ortho and gain share in major joints and extremities, but w...
Summary Stryker posted impressive top-line growth in Q4, driven by mid-teens growth in the MedSurg & Neuro operations. Margins remain a drag as Stryker has struggled to offset higher input costs. I see upside potential in FY'23 revenue, with Stryker launching several significant...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...